This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2018 Jan 11;378(2):158-168.

doi: 10.1056/NEJMra1703481.

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A Postow¹, Robert Sidlow¹, Matthew D Hellmann¹

Affiliations

PMID: 29320654
DOI: 10.1056/NEJMra1703481

Review

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A Postow et al. N Engl J Med. 2018.

. 2018 Jan 11;378(2):158-168.

doi: 10.1056/NEJMra1703481.

Authors

Michael A Postow¹, Robert Sidlow¹, Matthew D Hellmann¹

Affiliation

¹ From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York.

PMID: 29320654
DOI: 10.1056/NEJMra1703481

No abstract available

PubMed Disclaimer

Comment in

Adverse Events Associated with Immune Checkpoint Blockade.
Jhaveri KD, Perazella MA. Jhaveri KD, et al. N Engl J Med. 2018 Mar 22;378(12):1163. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29565518 No abstract available.
Adverse Events Associated with Immune Checkpoint Blockade.
Akturk HK, Michels AW. Akturk HK, et al. N Engl J Med. 2018 Mar 22;378(12):1163-4. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29565519 No abstract available.
Adverse Events Associated with Immune Checkpoint Blockade.
Kumar B, Ballas Z. Kumar B, et al. N Engl J Med. 2018 Mar 22;378(12):1164. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29565520 Free PMC article. No abstract available.
Adverse Events Associated with Immune Checkpoint Blockade.
Cohen Tervaert JW, Ye C, Yacyshyn E. Cohen Tervaert JW, et al. N Engl J Med. 2018 Mar 22;378(12):1164-5. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29565521 No abstract available.

Similar articles

[Toxicity of immune checkpoints inhibitors].
Delaunay M, Caron P, Sibaud V, Godillot C, Collot S, Milia J, Prévot G, Mazières J. Delaunay M, et al. Rev Mal Respir. 2018 Dec;35(10):1028-1038. doi: 10.1016/j.rmr.2017.08.006. Epub 2018 Sep 10. Rev Mal Respir. 2018. PMID: 30213624 Review. French.
[Sarcoid-like granulomatosis in cancer patients treated with immune checkpoints inhibitors].
Faviez G, Bousquet E, Rabeau A, Rouquette I, Collot S, Goumarre C, Meyer N, Prevot G, Mazieres J. Faviez G, et al. Rev Mal Respir. 2018 Nov;35(9):963-967. doi: 10.1016/j.rmr.2018.08.003. Epub 2018 Sep 13. Rev Mal Respir. 2018. PMID: 30220489 French.
Immunotherapy Toxicities.
Sanchez K, Page DB, Urba W. Sanchez K, et al. Surg Oncol Clin N Am. 2019 Jul;28(3):387-401. doi: 10.1016/j.soc.2019.02.009. Epub 2019 Apr 5. Surg Oncol Clin N Am. 2019. PMID: 31079795 Review.
[Immunotherapies of cancer: Is there any impact on patient cognitive functions?].
Castel H, Joly F. Castel H, et al. Med Sci (Paris). 2020 Aug-Sep;36(8-9):695-699. doi: 10.1051/medsci/2020139. Epub 2020 Aug 21. Med Sci (Paris). 2020. PMID: 32821042 French. No abstract available.
[No title available]
[No authors listed] [No authors listed] Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(4):263a. doi: 10.2177/jsci.40.263a. Nihon Rinsho Meneki Gakkai Kaishi. 2017. PMID: 29176294 Japanese. No abstract available.

See all similar articles

Cited by

Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer.
Ni J, Huang M, Zhang L, Wu N, Bai CX, Chen LA, Liang J, Liu Q, Wang J, Wu YL, Zhang FC, Zhang SY, Chen C, Chen J, Fang WT, Gao SG, Hu J, Jiang T, Li SQ, Li HC, Liao YD, Liu Y, Liu DR, Liu HX, Liu JY, Liu LX, Wang MZ, Wang CL, Yang F, Yang Y, Zhang LJ, Zhi XY, Zhong WZ, Guan YZ, Guo XX, He CX, Li SL, Li Y, Liang NX, Lu FL, Lv C, Lv W, Si XY, Tan FW, Wang HP, Wang JS, Yan S, Yang HX, Zhu HJ, Zhuang JL, Zhuo ML. Ni J, et al. Thorac Cancer. 2021 May;12(9):1469-1488. doi: 10.1111/1759-7714.13942. Epub 2021 Mar 30. Thorac Cancer. 2021. PMID: 33787090 Free PMC article.
The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity.
Hsu YO, Lu KL, Fu Y, Wang CW, Lu CW, Lin YF, Chang WC, Yeh KY, Hung SI, Chung WH, Chen CB. Hsu YO, et al. Front Immunol. 2021 Feb 26;12:597761. doi: 10.3389/fimmu.2021.597761. eCollection 2021. Front Immunol. 2021. PMID: 33717075 Free PMC article. Review.
Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies.
Liu G, Qiu Y, Zhang P, Chen Z, Chen S, Huang W, Wang B, Yu X, Guo D. Liu G, et al. Pharmaceutics. 2022 Aug 24;14(9):1762. doi: 10.3390/pharmaceutics14091762. Pharmaceutics. 2022. PMID: 36145510 Free PMC article. Review.
Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus.
Wang B, Zhang B, Wu M, Xu T. Wang B, et al. J Transl Autoimmun. 2024 Jul 27;9:100249. doi: 10.1016/j.jtauto.2024.100249. eCollection 2024 Dec. J Transl Autoimmun. 2024. PMID: 39228513 Free PMC article. Review.
Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions.
Winges KM, Gordon LK. Winges KM, et al. Front Ophthalmol (Lausanne). 2022 Nov 18;2:1044904. doi: 10.3389/fopht.2022.1044904. eCollection 2022. Front Ophthalmol (Lausanne). 2022. PMID: 38983573 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov